dc.contributor.author | Abdelsalam Elshenawy, Rasha | |
dc.date.accessioned | 2024-05-14T10:00:02Z | |
dc.date.available | 2024-05-14T10:00:02Z | |
dc.date.issued | 2024-05-13 | |
dc.identifier.citation | Abdelsalam Elshenawy , R 2024 , Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024) . Octopus . https://doi.org/10.57874/5kvv-sf51 | |
dc.identifier.other | ORCID: /0000-0002-8954-0817/work/159834906 | |
dc.identifier.uri | http://hdl.handle.net/2299/27876 | |
dc.description | Published on Octopus. This is an open access work distributed under the terms of the Creative Commons Attribution License (CC BY), https://creativecommons.org/licenses/by/4.0/ | |
dc.description.abstract | "Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024)" by R. Elshenawy provides a comprehensive analysis of antimicrobial use throughout the COVID-19 pandemic. This extensive four-year study focuses on antimicrobial stewardship (AMS) and antibiotic safety before and during the pandemic. Key phases include a systematic literature review, cross-sectional studies involving retrospective and prospective data, and preparation of detailed reports. The findings underscore significant shifts in antibiotic use, emphasising the need for robust AMS strategies to combat antimicrobial resistance (AMR). This report serves as a crucial resource for healthcare professionals, offering actionable recommendations to enhance AMS practices and ensure patient safety. | en |
dc.format.extent | 1048798 | |
dc.language.iso | eng | |
dc.publisher | Octopus | |
dc.subject | Final report | |
dc.subject | Antimicrobial stewardship | |
dc.subject | Antibiotic resistance | |
dc.subject | antimicrobial resistance | |
dc.subject | Healthcare | |
dc.subject | PhD studies | |
dc.subject | hospitals | |
dc.subject | research project | |
dc.subject | Medication safety | |
dc.subject | patient safety | |
dc.subject | Quality Improvement | |
dc.subject | TECHNOLOGY | |
dc.subject | quality improvement | |
dc.subject | reporting | |
dc.subject | Systematic review | |
dc.subject | Retrospective Studies | |
dc.subject | Prospective Studies | |
dc.subject | research method | |
dc.subject | Pharmacist role | |
dc.subject | Acute care setting | |
dc.title | Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024) | en |
dc.contributor.institution | School of Life and Medical Sciences | |
rioxxterms.versionofrecord | 10.57874/5kvv-sf51 | |
rioxxterms.type | Conference Paper/Proceeding/Abstract | |
herts.preservation.rarelyaccessed | true | |